Unless otherwise prescribed by your doctor, the usual dose is: At the start of treatment, 1 ml (1 ampoule) is administered once or twice a week for the first two weeks after diagnosis, corresponding to 1000-2000 g of cyanocobalamin per week
There's also intriguing data on the nervous system -- BPC-157 has shown neuroprotective effects in animal models of traumatic brain injury and spinal cord damage, and some research suggests it modulates dopamine and serotonin pathways in ways that could affect mood and addiction
There is no published experiment that bridges the two that is, no study measuring how much 5-Amino-1MQ reaches circulation after an oral dose versus a subcutaneous dose
Comprehensive Screening Protocols Prior to initiating treatment with BPC-157 or TB-500, healthcare professionals should conduct a comprehensive cancer risk assessment and screening protocol tailored to each patients individual risk profile
It demonstrates anti-inflammatory effects, helping with chronic discomfort and recovery